Sildenafil for Oral Suspension, 10 mg/mL has an estimated annual sales of USD 66 million in the U.S.
global pharma companies from India
Posted inPeople
Lupin announces change in executive leadership
Dr Fabrice Egros to assume responsibility as President, Global Corporate Development & Growth Markets.
Posted inSectors
Lupin introduces Molnupiravir under the brand name Molnulup for treatment of COVID-19
Clinical data points to its effectivity on patients with co-morbidities.